Pregnancy during enzyme replacement therapy for late-onset acid maltase deficiency
暂无分享,去创建一个
[1] S. Rudnik-Schöneborn,et al. 179th ENMC international workshop: Pregnancy in women with neuromuscular disorders 5–7 November 2010, Naarden, The Netherlands , 2012, Neuromuscular Disorders.
[2] M. Visser,et al. What we do not know about pregnancy in hereditary neuromuscular disorders , 2009, Neuromuscular Disorders.
[3] N. Salmón,et al. Anaesthetic management of an obstetric patient with Pompe disease. , 2008, International journal of obstetric anesthesia.
[4] R. Tawil,et al. Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy , 2006, Neurology.
[5] P. Doorn,et al. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. , 2006, Acta neurologica Belgica.
[6] W. Mooi,et al. Pathological features of glycogen storage disease type II highlighted in the knockout mouse model , 1999, The Journal of pathology.
[7] K. Zerres,et al. Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. , 1997, Archives of neurology.
[8] J. D. van der Walt,et al. The pattern of involvement of adult‐onset acid maltase deficiency at autopsy , 1987, Muscle & nerve.
[9] A. Patchefsky,et al. Case report 3 , 1976, Skeletal Radiology.
[10] M. Karadağ,et al. Sleep breathing disorders in pregnancy. , 2009, Tuberkuloz ve toraks.